Results In Line, But Weak Organic Growth
204 Views25 Mar 2016 11:00
China TCM's 2015 results met expectations (operating profit +56%/EPS +3%), but the shares have declined by roughly 11% in response to very tepid...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 44-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
- China Traditional Chinese Med (570 HK): Third Time's the Charm as Sinopharm Revives Its Interest?07 Feb 2024
- China Traditional Chinese Medicine Possible Privatisation30 Jan 2021
- Positive Tidbits to Consider05 Apr 2016
- Results In Line, But Weak Organic Growth25 Mar 2016
- Positive Profit Warning Suggests In-Line Results12 Mar 2016
- A Growing Market, Government Backing: What's Not to Like?09 Apr 2015
x